ArticleJournal of primary care & community health

Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists.

Anjay Rastogi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.